x min read

Dewmar International BMC (OTCMKTS:DEWM) Planning On A Big 2016

Dewmar International BMC (OTCMKTS:DEWM) Planning On A Big 2016
Written by
Alex Carlson
Published on
January 4, 2016
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

For almost all of 2015, Dewmar International BMC (OTCMKTS:DEWM) traded in a tight range. Shares look to be consolidating before making their next move higher. DEWM spiked 23% on the last trading day of 2015 after CEO Dr. Marco Moran issued an optimistic shareholder letter as we head into 2016.

What Will 2016 Bring For DEWM?

Sign Up Below And Find Out!

Dr. Moran's goal is to get the stock back to where it was in 2014 when shares hit $.03. Ever since then, DEWM has been stuck in sub penny land. A major overhang on the stock has been its toxic financings that lead to the company having an outstanding share count of 2.4 billion with a free float of 2.2 billion. Dr. Moran is well aware of this issue and addressed this in his annual shareholder letter.

"Dewmar International voided all of its toxic financers by end of March 2014, and in 2015 we kept our promise by not diluting our stock. As this year closes, the number of issued and outstanding shares still remains at 2,426,163,513 while maintaining the same float of 2,225,613,590 shares for the entire year. This is approximately the same number of shares in the float when our stock once was above 3 cents per share. Hopefully, this shows our level of commitment to our investors be more selective about our capital sources and frequency of financing has been the direct result of implemented cost controls and increased revenue."

There are number of things the company is working on to drive shares higher. For one, DEWM has hired Malone Bailey to audit its 2014 financials and bring its SEC filing status current. This will go a long way in re-establishing its credibility with the market and proving the naysayers wrong.

Second, on the products side, DEWM has a lot going on. DEWM is now selling PhysiPet, Yellow Jacket iPhone Stun Gun/Charger, Rocky Mountain High Hemp , C-Swiss Hemp Iced Tea, Chillo Hemp Energy, Canna Energy, Lean Slow Motion Potion and Kush Cakes through Amazon, Walmart and eBay. DEWM has negotiated new contracts that have allowed DEWM to gain full control of the manufacturing, sales, marketing and brand management rights of several of the aforementioned brands.

Third, Lean Slow Motion Protein has completed its third full year on Walmart shelves. DEWM hopes to ramp up its Lean sales by spending a minimum of $100,000 in targeted marketing across social media advertising, radio ads, in-store samplings and brand awareness campaigns.

Fourth, DEWM has not heard from the FDA since 2014 regarding labeling of its Lean Slow Motion Protein. According to DEWM:

The main issues the FDA cited involved non-compliant labels; is subsequently being changed to Dietary Supplement Facts labeling. There is no issue with LeanSMP as a Dietary Supplement containing melatonin as an active ingredient.

We Have A Monster Pick Coming Soon!

Sign Up Now!

Enter Your Email Below!

Fifth, the Kush Cakes line looks very promising. Initial sales to distributors and wholesalers exceeded expectations and created back orders while production ramped up in stages to ensure quality control. DEWM is also looking to develop new products around the Kush Cakes brand. One will include a special new brownie product with an existing client.

Lastly, its subsidiary Health & Wellness Research Consortium looks to become a major growth driver for the company. According to Dr. Moran:

The goal of this company is to develop and implement healthcare sales and marketing strategies for pharmacies, clinics and hospitals in order to help maximize the client’s income earning potential. We, in turn, share in the gain in profitability that our team of consultant helped to generate. The Consortium integrates strategic insight, operational excellence and a deep understanding of our specific target market to deliver results by matching a fertile new patient base with pharmacies, clinics and a variety of healthcare specialty care centers.Furthermore, the Consortium invests in healthcare technologies, innovative practices and high profit-margin diagnostic equipment while simultaneously creating value through strategic guidance, operational insights, and industry strategy. We provide our partners and clients with the unique insight to drive critical decision making, improve their performance and achieve sustained profitable growth. As shown in the unaudited 8K financials, the Consortium was responsible for millions of dollars of revenue earnings in 2014. Our upcoming audited financials will show that his revenue trend has been sustained throughout 2015.

As you can see DEWM has a lot of exciting things happening. The key is delivering on all of these developments. We will be watching DEWM closely for a breakout. Don't miss the next move in DEWM! Sign up for our alerts on DEWM and all of our hot stock picks.Disclosure: We own no shares of DEWM and have not been compensated for this article.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You